Taiwan Liposome Company, Ltd. (GTSM:4152) announced a private placement of 30,000,000 common shares on January 25, 2019. The shares are issued at par value of TWD 10. The transaction is approved by board of directors of the company. The transaction is subject to shareholders approval.